Literature DB >> 24490205

[Not Available].

J Dinger, S Nitschmann.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24490205

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  5 in total

Review 1.  Benefits and risks of oral contraceptives.

Authors:  K Sherif
Journal:  Am J Obstet Gynecol       Date:  1999-06       Impact factor: 8.661

2.  Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution.

Authors:  Marianne Tang Severinsen; Søren Risom Kristensen; Kim Overvad; Claus Dethlefsen; Anne Tjønneland; Søren Paaske Johnsen
Journal:  J Clin Epidemiol       Date:  2010-02       Impact factor: 6.437

3.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

4.  Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9.

Authors:  Øjvind Lidegaard; Lars Hougaard Nielsen; Charlotte Wessel Skovlund; Finn Egil Skjeldestad; Ellen Løkkegaard
Journal:  BMJ       Date:  2011-10-25

5.  Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10.

Authors:  Ojvind Lidegaard; Lars Hougaard Nielsen; Charlotte Wessel Skovlund; Ellen Løkkegaard
Journal:  BMJ       Date:  2012-05-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.